ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $119,731 | -11.7% | 58,981 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $135,656 | -24.1% | 58,981 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $178,713 | +73.8% | 58,981 | +33.6% | 0.00% | 0.0% |
Q4 2022 | $102,835 | -7.9% | 44,135 | -24.5% | 0.00% | 0.0% |
Q3 2022 | $111,651 | +17.2% | 58,456 | +66.3% | 0.00% | 0.0% |
Q2 2022 | $95,240 | -19.4% | 35,144 | -11.3% | 0.00% | 0.0% |
Q1 2022 | $118,091 | +204.2% | 39,628 | +297.1% | 0.00% | – |
Q4 2021 | $38,822 | -69.9% | 9,980 | -66.8% | 0.00% | -100.0% |
Q3 2021 | $128,880 | -26.6% | 30,042 | +61.7% | 0.00% | -50.0% |
Q3 2018 | $175,562 | – | 18,578 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
Shay Capital LLC | 60,000 | $257,000 | 0.03% |
Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |